WallStSmart
OMER

Omeros Corporation

NASDAQ: OMER · HEALTHCARE · BIOTECHNOLOGY

$14.60
+0.27% today

Updated 2026-04-30

Market cap
$1.06B
P/E ratio
P/S ratio
4.43x
EPS (TTM)
$-0.08
Dividend yield
52W range
$3 – $18
Volume
1.1M

Omeros Corporation (OMER) Financial statements

SEC filings — annual and quarterly data.

Cash flow — annual

Item20062007200820092010201120122013201420152016201720182019202020212022202320242025
Operating cash flow$-10.17M$-14.31M$-19.67M$-19.03M$-14.50M$-25.67M$-34.55M$-29.70M$-58.04M$-65.21M$-51.50M$-36.23M$-103.74M$-60.07M$-100.09M$-109.72M$-86.48M$74.73M$-148.80M$-116.09M
Capital expenditures$166000.00$534000.00$164000.00$279000.00$8.44M$1.24M$642000.00$204000.00$28000.00$240000.00$126000.00$350000.00$567000.00$334000.00$283000.00$277000.00$113000.00$426000.00$165000.00$65000.00
Depreciation
Stock-based comp$1.44M$6.06M$2.31M$1.49M$2.18M$1.93M$4.28M$6.25M$8.92M$9.58M$13.58M$12.69M$11.71M$13.79M$14.93M$17.63M$14.07M$11.65M$10.49M$8.19M
Free cash flow$-10.34M$-14.85M$-19.84M$-19.31M$-22.94M$-26.91M$-35.19M$-29.90M$-58.07M$-65.45M$-51.63M$-36.58M$-104.30M$-60.41M$-100.37M$-110.00M$-86.60M$74.30M$-148.97M$-116.16M
Investing cash flow
Financing cash flow
Dividends paid$3.15M$0.00$0.00$0.00$0.00$0.00$0.00
Share repurchases
Debt repayment
Net change in cash$727000.00$-2.48M$-136000.00$-1.03M$1.01M$859000.00$1.17M$2.47M$-2.78M$7.42M$90.31M$-89.80M